OMAR ZAPATA: Open Payments
NPI 1821500596 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,181 in 72 payments from 14 companies in 2025. Trend: 2023 $422 · 2024 $374 · 2025 $1,181
Food & beverage: $1,165Gift: $16
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $247 |
| Vanda Pharmaceuticals Inc. | 14 | $239 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $176 |
| Indivior Inc. | 9 | $151 |
| Janssen Pharmaceuticals, Inc | 5 | $135 |
| Supernus Pharmaceuticals, Inc. | 3 | $50 |
| Tris Pharma Inc | 2 | $31 |
| Lundbeck LLC | 1 | $30 |
| TOLMAR, INC. | 1 | $26 |
| Alkermes, Inc. | 1 | $24 |
Products named: VRAYLAR, FANAPT, CAPLYTA, SUBLOCADE, SPRAVATO, REXULTI, Qelbree, JATENZO.
Industry payments across LA — which companies pay providers there.
